Acorda Therapeutics
Acorda Therapeutics is a biotechnology company that develops therapies for neurological disorders. The company is headquartered in Ardsley, New York.
History[edit | edit source]
Acorda Therapeutics was founded in 1995 by Ron Cohen, M.D., with the mission to develop therapies that restore function and improve the lives of people with neurological disorders. The company initially focused on developing treatments for spinal cord injury and later expanded its research to include other neurological conditions such as multiple sclerosis (MS) and Parkinson's disease.
Products[edit | edit source]
Acorda Therapeutics is known for developing several key products in the field of neurology:
- Ampyra (dalfampridine): A medication approved by the Food and Drug Administration (FDA) to improve walking in patients with multiple sclerosis. It works by blocking potassium channels on the surface of nerve cells, which helps improve nerve signal conduction.
- Inbrija (levodopa inhalation powder): An inhaled form of levodopa used to treat "off" episodes in patients with Parkinson's disease who are already taking a carbidopa/levodopa regimen. It provides rapid relief from symptoms by delivering levodopa directly to the bloodstream through the lungs.
Research and Development[edit | edit source]
Acorda Therapeutics invests heavily in research and development to discover new treatments for neurological disorders. The company's R&D efforts focus on innovative drug delivery systems and novel therapeutic targets. Acorda collaborates with academic institutions and other biotechnology companies to advance its research pipeline.
Corporate Structure[edit | edit source]
Acorda Therapeutics operates as a publicly traded company on the NASDAQ stock exchange under the ticker symbol "ACOR." The company is governed by a board of directors and led by a team of executives with extensive experience in the biotechnology and pharmaceutical industries.
Community Involvement[edit | edit source]
Acorda Therapeutics is committed to supporting the neurological community through various initiatives. The company sponsors educational programs, patient advocacy groups, and research foundations to raise awareness and improve the quality of life for individuals with neurological disorders.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
